A search for C 35 -terpenes from non-saponified extracts of 12 non-pathogenic Mycobacterium species was carried out. Octahydroheptaprenyl mycolic acyl esters were isolated from M. chlorophenolicum cells which were also found from M. thermoresistibile, M. vanbaalenii, M. aichiense, M. smegmatis, and M. parafortuitum. This is the first report on a polyprenol esterified by a mycolate. A novel monocyclic C 35 -terpene possessing a ketone, named heptaprenylcycline B, was isolated, which was detected from M. chlorophenolicum and M. vanbaalenii. The biosynthetic pathway to heptaprenylcycline B was investigated with ancymidol which acts as an inhibitor of a P450 monooxygenase. This experiment suggested that the P450 monooxygenase may be responsible for the production of heptaprenylcycline B.
Terpenoids comprise a very large family of natural products with more than 23,000 structurally diverse compounds. In general, terpenoids are categorized by the number of C 5 isoprene units as follows: hemi-(C 5 ), mono-(C 10 ), sesqui-(C 15 ), di-(C 20 ), sester-(C 25 ), tri-(C 30 ), and tetraterpenes (C 40 ). We have recently found C 35 -terpene 1, heptaprenylcycline, from non-pathogenic Mycobacterium species (Fig. 1 ) 1) and demonstrated that 1 was produced by the cyclization reaction of octahydroheptaprenyl diphosphate (2-PP) (Fig. 1) . 1) A cyclic terpenoid biosynthesized via cyclization of a linear C 35 -isoprenoid such as 1 has not been found before.
1) Bosak et al. have recently proposed that the cyclic C 35 -terpenes isolated from Bacillus subtilis, tetraprenylcurcumenes and sporulenes, were also produced via the cyclization of a linear C 35 -isoprenoid. 2, 3) Further study would be required to elucidate the biosynthetic pathways and physiological functions of these rare C 35 -terpenes recently found from Mycobacterium and B. subtilis.
To date, the search for other C 35 -terpene metabolites involved in Mycobacterium has been insufficient. Our previous study suggested that an unknown compound, which possessed 2 as a moiety, existed in Mycobacterium species, because 2 was not detected in nonsaponified (no alkaline treatment) samples. 1) We isolated in this present study novel compound 3 possessing 2, an octahydroheptaprenyl mycolic acyl ester, from non-saponified extracts (Fig. 1) . It is well known that the genus Mycobacterium produces characteristicbranched -hydroxy fatty acids named mycolic acids.
4)
However, mycolic acid derivative 3 possessing a polyprenol has not been reported before. In addition to 3, we isolated novel compound 4, which is a monocyclic C 35 -terpene possessing a ketone, and propose to name it heptaprenylcycline B (Fig. 1 ). An experiment using a P450 inhibitor suggested that compound 4 would be produced by the catalysis of a P450 monooxygenase.
Materials and Methods
General procedure. NMR spectra were recorded by a Bruker DMX 600 spectrometer at 600 MHz for protons and 125 MHz for carbons. GC-MS was performed with an SX 102 spectrometer (Jeol) equipped with a DB-1 capillary column (30 m Â 0:25 mm Â 0:25 mm; J&W Scientific.) and using the EI mode operated at 70 eV, or with a JMS-Q1000 GC K9 instrument (Jeol) equipped with a ZB-5ms capillary column (30 m Â 0:25 mm Â 0:25 mm; Zebron) and using the EI mode operated at 70 eV. HRMS was performed by using a direct inlet system. The specific rotation was measured at 25 C by a Horiba SEPA-300 polarimeter. The IR spectrum was recorded by an FT/IR-4200 instrument (Jasco). MPLC was performed by a YFLC instrument (Yamazen, Kyoto, Japan; 540 pump and UV-10V), and HPLC was performed with an SPD-10A detector and LC-10AS pump (Shimadzu).
Bacterial strains and culture conditions. The following 12 Mycobacterium species were employed in this study: M. agri JCM 6377, M. aichiense JCM 6376, M. aurum JCM 6366, M. chlorophenolicum JCM 7439, M. diernhoferi JCM 6371, M. moriokaense JCM 6375, M. nonchromogenicum JCM 6364, M. parafortuitum JCM 6367, M. pulveris JCM 6370, M. smegmatis JCM 6386, M. thermoresistibile JCM 6362, and M. vanbaalenii JCM 13017. All these Mycobacterium species were reciprocally shake-cultured at an optimal temperature (28 C for M. chlorophenolicum and M. vanbaalenii, and 37 C for the others) until the stationary growth phase had been achieved (4 d for M. chlorophenolicum and 3-14 d for the other species). They were shake-cultured in 3000-ml Sakaguchi flasks, each containing 1000 ml of a medium containing 1% polypeptone (Nihon Seiyaku), 0.5% yeast extract (Oxoid), 0.5% malt extract (Difco), 0.5% casamino acids (Nihon Seiyaku), 0.2% glycerol (Wako), 0.005% Tween 80 (Wako), and 0.1% MgSO 4 . 7H 2 O (Kanto Chemical).
Preparation and GC-MS analysis of the lipid fraction obtained from cells and the broth filtrate. The cells of each bacterial species obtained y To whom correspondence should be addressed. Fax: +81-25-262-6854; E-mail: satot@agr.niigata-u.ac.jp Abbreviations: GC-MS, gas chromatography-mass spectrometry; NMR, nuclear magnetic resonance; MPLC, medium-pressure liquid chromatography; HPLC, high-performance liquid chromatography; EI, electron impact ionization; HR, high resolution from 1 liter of the culture medium were collected by centrifugation (6000 Â g at 4 C for 10 min). After lyophilization, the cells were extracted with MeOH (200 ml Â 3). The MeOH fraction was partitioned with n-hexane (600 ml Â 3). On the other hand, the broth filtrate was extracted with EtOAc (1 liter Â 3). GC-MS was performed with an injection temperature of 290 C and oven temperature of 220-290 C at a rate of 3 C min À1 .
Isolation of compounds 3 and 4. M. chlorophenolicum was cultured in an 80 Â 1 liter medium at 28 C for 4 d. The lyophilized cells (456 g dry weight) were extracted with MeOH (6:4 l Â 3). The MeOH fraction was partitioned with n-hexane (6:4 l Â 3). The n-hexane layer (7.5 g dry weight,) was partially purified by silica gel (400 g) column chromatography with n-hexane and EtOAc. The fraction eluted with n-hexane (152 mg) was again subjected to silica gel (40 g) column chromatography with n-hexane, affording 20.5 mg of pure compound 1. The fraction eluted with EtOAc (3.1 g) was subjected to silica gel (200 g) column chromatography with gradient elution (n-hexane/ EtOAc = 100/1 À 100/20). Pure 4 (0.9 mg) was obtained by SiO 2 MPLC with n-hexane/EtOAc (100:0.3) and followed by reverse-phase HPLC (Shiseido, Capcell Pak C18) with MeOH/THF (100:5). On the other hand, 3 was acetylated (Ac 2 O in pyridine at room temperature for 16 h) after being purified by silica gel column chromatography, because the other materials involved in the fraction were not acetylated. Pure acetylated 3 (5.5 mg) was obtained by reverse-phase HPLC with MeOH/THF (100:65).
Conversion of mycolic acid to TMS-methyl mycolate. Mycolic acid was converted to a methyl ester by refluxing with 3 ml of benzene/ MeOH/H 2 SO 4 (10:20:3) for 2 h. After the product had been extracted with n-hexane (4 ml Â 3), methyl mycolate was trimethylsilylated for 20 min with BSTFA/pyridine (2:1) at 70 C. The trimethylsilyl ether derivative of methyl mycolate was analyzed by EIMS. Analyses for the amounts of 1, 3, and 4 in cultured cells treated by ancymidol. Ancymidol was purchased from Sigma-Aldrich Japan. M. chlorophenolicum was inoculated into 30 ml of a medium containing 1 mM ancymidol and cultured for 8 d (stationary phase). The growth curve for mycobacteria treated by ancymidol was almost the same as that for the untreated compound. After the lipid fractions had been extracted, the amounts of 1, 3, and 4 were estimated by GC-MS. This experiment was carried out twice.
Instrumental data for heptaprenylcycline B (4). Colorless oil; ½

Results and Discussion
Search for and isolation of C 35 -terpenes The non-saponified lipids from the 12 mycobacteria cells were subjected to a GC-MS analysis ( Table 1 ). The EIMS data for compound 3 were similar to those for 2 ( Figs. 2 and 3 ). Since 2 was not detected by TLC (R f 0.5 in n-hexane/EtOAc 100:20), we assumed that 3 would be a novel compound. Compound 3 was detected from the extracts of M. chlorophenolicum, M. thermoresistibile, M. vanbaalenii, M. aichiense, M. smegmatis, and M. parafortuitum (Table 1 ). In addition, compound 4, whose EIMS data were similar to those of 1, was also detected as a minor component from the extracts of M. chlorophenolicum and M. vanbaalenii (Figs. 2 and 3, Table 1 ).
Among the 12 mycobacteria, M. chlorophenolicum produced the largest amounts of 3 and 4. We therefore employed M. chlorophenolicum cells to isolate 3 and 4. After cultivating 80 liter of M. chlorophenolicum, the lipophilic materials from the non-saponified cells were first extracted with MeOH, and the MeOH fraction was partitioned with n-hexane. The n-hexane extracts were subjected to silica gel column chromatography, followed (2) were obtained from a saponified fraction in the previous study.
1) It was demonstrated that 1 was produced by the cyclization of 2-PP.
1) We found in this study octahydroheptaprenyl mycolic acyl esters (3) and heptaprenylcycline B (4) from the non-saponified extracts. 
by SiO 2 MPLC and reverse-phase HPLC, respectively yielding 20.5 mg, 5.5 mg, and 0.9 mg of 1, acetylated 3, and 4.
Structure of compound 3
The 1 H-NMR spectrum of acetylated 3 was similar to that of 2. However, many signals corresponding to ca. 100 H were detected at 1.4-1.6 ppm. HMBC analyses of acetylated 3 indicated that the octahydroheptaprenyl (2) moiety was connected to an unidentified moiety as shown in Fig. 4 . Since these data for the unknown moiety were consistent with the structure of mycolic acid, 4) we deduced that 3 was octahydroheptaprenol (2) esterified by mycolic acid. In order to confirm the structure of 3, 1 mg of acetylated 3 was degraded to octahydroheptaprenol (2) by saponification (75 C for 30 min with 1 ml of 15% KOH in 95% aqueous MeOH). Compound 2 was extracted with n-hexane (1 ml Â 3) and identified by GC-MS and 1 H-NMR by comparing with an authentic sample that we had previously isolated. 1) On the other hand, the mycolic acid moiety was extracted with n-hexane (1 ml Â 3) after acidifying the aqueous phase. As reported in ref. 5 , the characteristic fragmentation patterns of TMS-methyl mycolate through EIMS are useful for the identifying a mycolate (Fig. 5) . Thus, mycolic acid was converted to TMSmethyl mycolate as described in the Materials and Methods section, and the derivative was analyzed by EIMS with a direct inlet system. From the m=z values corresponding to [M] þ , ½M À 15 þ , and ½M À 90 þ , the original structures of the mycolates were determined as a mixture of C 62:1 and C 64:1 ( Fig. 5 and Table 2 ), whose ion intensity was ca. 1:2. Fragment ions of [A] þ and ½A À 90 þ indicated that the -units were C 38:1 and C 40:1 ( Fig. 5 and Table 2 ). [B] þ and ½B À 29 þ revealed that both -units were C 24:0 (Fig. 5 and Table 2 ). The mycolates of C 62:1 and C 64:1 have been reported to be isolated from M. smegmatis.
5) The whole structure of 3 is shown in Fig. 1 .
Mycolic acids are well known as the components of a major cell envelope and found as the mycolylarabinogalactan-peptidoglycan complex, mycolyl-trehalose or mycolyl-glycerol. These types of mycolic acidcontaining components are believed to play a crucial role in the structure and function of the mycobacterial cell envelope. 4) Mycolic acids attached to the cell wall arabinogalactan are organized with other lipids to form an outer permeability barrier that results in extremely low fluidity and exceptionally low permeability to mycobacteria; this may also explain their intrinsic resistance to many antibiotics. 4) Mycolyl-trehalose has been implicated in numerous biological functions related to both the physiology and virulence of M. tuberculosis. 4) On the other hand, mycolic acid esterified by polyprenol, such as 3, has not previously been reported. Studies on the physiological function of polyprenyl mycolic acyl esters may in future help in elucidating the structure and function of the mycobacterial cell envelope. A, compound 2; B, compound 3 (RT, 31.3 min in Fig. 2) ; C, compound 3 (RT, 32.4 min in Fig. 2 ).
Structure and biosynthesis of compound 4
The structure of 4 was determined by NMR (DEPT, COSY, HOHAHA, NOESY, HMQC, and HMBC), EIMS, and IR data. The complete NMR assignments are shown in Table 3 . The 13 C-NMR signal (212.4 ppm) and IR absorption band (1714 cm À1 ) indicate the existence of a carbonyl group. The molecular formula of 4 was assigned as C 35 H 62 O on the basis of the HR-EIMS data. As shown in Fig. 6 , the position of the ketone was determined by NMR (COSY, HOHAHA, and HMBC) and EIMS (fragment ion m=z 211 and 315) data. Clear NOE was observed between H-10 ( H 5.41, t, J 6.9) and Me-30 ( H 1.85, s), indicating that H-10 and Me-30 were arranged in the Z-configuration. A comparison of the chemical shift of C-12 (32.33 ppm) with that of C-12 in ficaprenol 6) (Z, ca. 32.0 ppm; E, ca. 40.0 ppm) further supported the Z-geometry. Compound 4 is novel, and we therefore propose to name it heptaprenylcycline B.
The structure of 4 suggests that it is a metabolite of 1 (Fig. 1) . We assumed that the P450 monooxygenase may be responsible for the conversion of 1 to 4, because the P450 enzyme is known to transform alkanes to ketones in the biosynthesis of many kinds of terpenes. [7] [8] [9] In order to examine whether P450 was responsible for this oxygenation, an experiment was carried out with ancymidol which inhibits P450s in the biosynthesis of such terpenes as gibberellin, 7) trichothecene, 8) and aphidicolin. 9) M. chlorophenolicum was inoculated into the medium containing 1 mM ancymidol and was cultured for 8 d (stationary phase). The actions of P450s for the biosynthesis of other terpenes were inhibited at the concentration of 1 mM, [7] [8] [9] and at a concentration higher than 1 mM, the growth of mycobacteria was suppressed. As shown in Fig. 7 , GC-MS analyses of the lipid fractions revealed that the amount of 1 increased (197%), that of 4 decreased (42%), and that of 3 remained unchanged when compared with no treatment of ancymidol (control). This result suggests that P450 was responsible for the conversion of 1 to 4. Genomic analyses of M. vanbaalenii and M. smegmatis were completed among the 12 species employed in this study (Table 1) . Compound 4 was found from M. vanbaalenii, but no detectable amount of 4 was found from M. smegmatis (Table 1) . Forty-nine and 39 P450 homologs have respectively been found in the genomes of M. vanbaalenii and M. smegmatis.
10) The genomic comparison between M. vanbaalenii and M. smegmatis may lead to the selection of a candidate gene of the P450 producing 4. We could not previously detect any gene that was homologous to the known terpene cyclase in the genome of M. vanbaalenii. 1) We thus propose that a novel type of terpene cyclase converting 2-PP to 1 may exist in the Mycobacterium species.
1) The genomic analysis of a flanking region around P450 may help to identify this terpene cyclase, since it is known that both terpene cyclases and P450 exist as a cluster in the genome of microorganisms. 11, 12) In conclusion, the isolation and structural determination of compound 3, which could not be identified in the previous study, 1) was achieved by searching the nonsaponified extracts of mycobacterial cells. This is the first report on a polyprenol esterified by a mycolate. A novel cyclic C 35 -terpene possessing a ketone (4) was also found. The structure of 4 suggested that it was the metabolite of 1. An experiment with ancymidol suggested that P450 was responsible for the conversion of 1 to 4. These findings will be useful in elucidating the biosynthetic pathway to and physiological function of mycobacterial C 35 -terpenes in future. 
